Dow Jones futures rose Thursday after surprise weekly jobless claims. Nvidia partner Arm stock tumbled on earnings, while ...

The Bridgewater, N.J., biopharmaceutical company said brensocatib has the potential to become the first and only approved treatment for non-cystic fibrosis bronchiectasis, which causes the lungs' ...

Eton Pharmaceuticals said the Food and Drug Administration has extended by three months its review of the company's application seeking approval of its ET-400 liquid formulation of hydrocortisone.

Find insight on WeChat, Apple, U.S. tariffs and more in the latest Market Talks covering Technology, Media and Telecom.